REFLECT Scoliosis System Post Approval Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorGlobus Medical Inc

About this trial

The purpose of this multi-center, prospective, single-arm registry Post-Approval Study (PAS) is to evaluate the radiographic and clinical outcomes of 100 patients with idiopathic scoliosis treated with the REFLECT™ Scoliosis Correction System, as a condition of HDE approval

Eligibility criteria

Qualifiers

Diagnosis of progressive idiopathic scoliosis

Preoperative major Cobb angle 30°-65°

Preoperative flexibility to ≤30° on side bending radiograph (left or right)

Skeletally immature at the time of surgery with Risser sign <5 or Sanders score <8

Disqualifiers

Prior spinal surgery at the level(s) to be treated

Documented poor bone quality, defined as a T-score of -1.5 or less

Presence of any systemic infection, local infection, or skin compromise at the surgical site

Any medical or surgical condition which would preclude the potential benefit of spinal surgery, such as coagulation disorders, allergies to the implant materials, and patient's unwillingness or inability to cooperate with post-operative care instructions

Trial design

Treatments tested in this trial

  • REFLECT Scoliosis Correction System

Treatment groups

100 Participants
are divided into 1 treatment group

Sponsors and collaborators